ArticleColloids and surfaces. B, Biointerfaces2021

Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy.

N Sanoj Rejinold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.